Alphatec (ATEC) investor relations material

Market opportunity and growth strategy

• Spine surgery market estimated at $10 billion, with current penetration under 10%.

• Lateral surgery market sized at $1 billion, identified as a fast-growing segment due to clinical benefits.

• Focus on clinical distinction and procedural adoption to drive surgeon engagement and market share.

• Consistent 20% quarterly growth in surgeon adoption since 2024.

• Platform approach encourages expansion into broader pathologies and portfolio adoption.

Innovation and technology integration

• Investment in patient positioners and neuromonitoring enhances lateral surgery safety and reproducibility.

• EOS imaging system and AI-driven EOS Insight software enable automated alignment and longitudinal patient tracking.

• Sites using EOS Insight saw 30% volume growth within six months of implementation.

• Launch of Valence navigation and surgical robot platform integrated into PTP for predictable lateral surgery.

• Robotic and navigation tools broaden accessibility for surgeons with varying lateral experience.

International expansion and financial performance

• Strategy focuses on deep penetration in select countries, with recent entries into Australia, New Zealand, and Japan.

• First PTP procedure performed in Japan in March, supporting direct sales and higher profitability.

• Profitability improved from negative to positive adjusted EBITDA in 2024, with positive cash flow projected through 2026.

• Refinanced $200 million in term debt, saving $6 million annually in interest.

• 2026 guidance targets 15% revenue growth to $882 million, $134 million EBITDA, and $20 million free cash flow.